









The once weekly injection that helped redefine weight loss, working with your own appetite signals.
FDA-approved GLP-1 treatment
Reviewed by licensed US providers
Fast, discreet delivery and ongoing support

Wegovy® pen
Type of Medicine
Once weekly GLP-1 injection for chronic weight management
Generic
No
Active Ingredient
Semaglutide, supplied in weekly prefilled pens
Effective Within
Reduced hunger is often felt inside the first month, with the weight itself coming down progressively over the following several months.
Works By
Mimics the natural GLP-1 fullness hormone, so you feel satisfied sooner and stay satisfied longer.
Side Effects
Nausea is the headline early effect, usually fading within weeks, often joined by changes in bowel habit and the occasional bout of reflux. Gallbladder issues are an uncommon but recognized risk.
Novo Nordisk
Wegovy® pen
Novo Nordisk
Wegovy® pill
Novo Nordisk
Ozempic®
Novo Nordisk
Wegovy® pen
Novo Nordisk
Wegovy® pill
Novo Nordisk
Ozempic®One injection once a week.
One tablet once a day
One injection once a week.
Lose around 15–19% of body weight, depending on dose*
Lose around 14% of body weight*
Not licensed for weight management. But it can be prescribed off-label.
People who prefer a weekly routine
People who prefer no needles
People who prefer a weekly routine
Inject under the skin using a pre-filled pen
Take on an empty stomach with water
Inject under the skin using a pre-filled pen
Cash-pay or insurance may be available
Cash-pay only
Cash-pay or insurance may be available
Few medicines have changed a field the way Wegovy has. Its active ingredient, semaglutide, mimics a natural hormone the gut releases after eating, the one that tells the brain you have had enough. Topped up week after week, that signal becomes steady rather than fleeting, and appetite settles accordingly.
The effect on weight has been substantial and well documented across the large STEP research program, alongside a separate approval for reducing the risk of heart attack and stroke in certain adults who carry excess weight. For many, the quiet shift is psychological as much as physical, the constant background noise around food simply turns down.
Wegovy is injected just under the skin once a week from a prefilled pen. The dose rises in stages over the first months, which is the key to keeping early nausea brief and mild.
As a GLP-1 medicine, Wegovy carries a boxed warning about a rare thyroid tumor seen in animal studies and is not suitable for anyone with a history of medullary thyroid cancer or MEN 2. Available on prescription.
Semaglutide as the active ingredient, in a sterile solution for injection.
From question to doorstep, in days not weeks.
Real people. Real progress. Real support.

